Literature DB >> 29450318

Ophthalmological implications of the chronic infections with the hepatitis C Virus.

Alexa Anisia-Iuliana1, Cantermir Alina2, Ciuntu Roxana Elena1, Chiseliţă Dorin1,3.   

Abstract

Objectives. Report of a clinical case reuniting the dry eye syndrome in a severe form, the Mooren's ulcer and necrotizing anterior scleritis with inflammation, with bilateral affectation in the context of chronic infection with the hepatitis C virus. Methods. A female patient aged 66 diagnosed with chronic hepatitis with HCV, with ophthalmological antecedents of Mooren's ulcer and severe form of dry eye syndrome in both eyes, comes to the emergency unit with hypopyon corneal ulcer in the right eye, shortly afterwards developing necrotizing anterior scleritis with inflammation. The patient is administered treatment for chronic hepatitis C, following which the ARN-HCV viremia decreases without ocular exacerbations. When the viremia level increases again, two lesions indicating necrotizing anterior scleritis are observed in the left eye. The evolution is favourable with topical and systemic treatment with corticosteroids. Complicated cataract is surgically treated in the right eye and vitreous humour is collected during surgery. Results. Visual acuity increases in the right eye after the surgery, while antibodies-HCV are identified in the vitreous humour. Conclusions. Chronic infection with hepatitis C virus displays multiple extra-hepatic manifestations and the ophthalmological ones require a multidisciplinary approach from both the chronic diseases practitioner and the ophthalmologist.

Entities:  

Keywords:  Mooren’s ulcer; dry eye syndrome; hepatitis C virus; necrotizing anterior scleritis

Year:  2015        PMID: 29450318      PMCID: PMC5712950     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  27 in total

Review 1.  Scleritis.

Authors:  Narciss Okhravi; Bola Odufuwa; Peter McCluskey; Susan Lightman
Journal:  Surv Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 6.048

2.  Anterior scleritis, scleral thinning, and intraocular pressure measurement.

Authors:  Maged Nessim; Ioannis Kyprianou; Vinod Kumar; Philip I Murray
Journal:  Ocul Immunol Inflamm       Date:  2005-12       Impact factor: 3.070

3.  Ophthalmological complications in hepatitis C virus infection: side effect of interferon therapy or a direct role of HCV?

Authors:  Valerio Pazienza
Journal:  Biomed Pharmacother       Date:  2011-05-30       Impact factor: 6.529

4.  Treatment of Mooren's ulcer with topical administration of interferon alfa 2a.

Authors:  Uzeyir Erdem; Hurkan Kerimoglu; Fatih Cakir Gundogan; Selim Dagli
Journal:  Ophthalmology       Date:  2007-01-02       Impact factor: 12.079

5.  Decreased tear lactoferrin concentration in patients with chronic hepatitis C.

Authors:  T Abe; A Nakajima; M Matsunaga; S Sakuragi; M Komatsu
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

Review 6.  Global burden of disease (GBD) for hepatitis C.

Authors: 
Journal:  J Clin Pharmacol       Date:  2004-01       Impact factor: 3.126

7.  Hepatitis C and ocular surface disease.

Authors:  Christina Jacobi; Hartmut Wenkel; Arnd Jacobi; Klaus Korn; Claus Cursiefen; Friedrich E Kruse
Journal:  Am J Ophthalmol       Date:  2007-09-17       Impact factor: 5.258

Review 8.  Ocular manifestations of hepatitis C virus infection.

Authors:  Michael E Zegans; William Anninger; Christopher Chapman; Stuart R Gordon
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

9.  Immunopathology of necrotising scleritis.

Authors:  Yoshihiko Usui; Jignesh Parikh; Hiroshi Goto; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2008-03       Impact factor: 4.638

Review 10.  Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection".

Authors:  Cees G M Kallenberg; Henko Tadema
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.